Filing Details

Accession Number:
0000874716-24-000131
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-09 16:18:53
Reporting Period:
2024-09-05
Accepted Time:
2024-09-09 16:18:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1094176 Anne M Szostak One Idexx Drive
Westbrook ME 04092
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-09-05 500 $0.00 6,061 No 4 G Indirect Trust of M. Anne Szostak
Common Stock Acquisiton 2024-09-05 500 $0.00 500 No 4 G Indirect The O'Hanian-Szostak Family Foundation
Common Stock Disposition 2024-09-06 500 $469.37 0 No 4 S Indirect The O'Hanian-Szostak Family Foundation
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 G Indirect Trust of M. Anne Szostak
No 4 G Indirect The O'Hanian-Szostak Family Foundation
No 4 S Indirect The O'Hanian-Szostak Family Foundation
Footnotes
  1. The reporting person is the settlor of the Trust of M. Anne Szostak ("Trust") and the trustee of the Trust, has power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust. The reporting person has a pecuniary interest in the shares held by the Trust.
  2. The reporting person is a trustee of The O'Hanian-Szostak Family Foundation ('Foundation') and has power to direct the distribution of assets held by the Foundation.
  3. Represents the weighted average price of the shares sold ranging from a low of $468.98 to a high of $469.55 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.